glp 1 overview GLP-1 for Weight Loss and Diabetes GLP-1 actions and target organs.

While the risk of initiating TNF- inhibitors (adjusted IRR: 0.56, 95% CI: 0.321.00) and IBD-related surgery (adjusted IRR: 0.79, 95% CI: 0.571.09) was also reduced, these associations were not statistically significant

doi: 10.1016/j.bbrc.2017.11.076

Disclaimers and Disclosures Content and Medical Disclaimer

During GLP-1 therapy, some patients experience strong appetite reduction

Agents with proven cardiovascular benefits include Liraglutide, subcutaneous Semaglutide, and Dulaglutide (6)(12)(22)

Instead, by improving metabolic regulation and reducing chronic inflammatory stress, GLP-1 signaling may alter the cellular environment in ways that support more effective management of accumulated molecular damage